Weight optimization · Launchpad care path

Macro GLP-1s — semaglutide and tirzepatide on the partner care path.

OpenLoop Launchpad includes compounded semaglutide and tirzepatide on one contract. After you see if you qualify, intake is hosted by OpenLoop: their clinicians review, and their licensed 503A pharmacy network fills a patient-specific prescription if appropriate. Compounded GLP-1s are not FDA-approved branded products and are not generic equivalents of Wegovy, Ozempic, Zepbound, or Mounjaro. Care is not live until Launchpad is wired.

At a glance

What this page is built to clarify.

Care-path focus

On the Launchpad contract

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Care-path focus

Partner clinicians decide

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Care-path focus

Not a branded-drug substitute

Livozo is the brand and marketing site only. Clinical decisions, if any, sit with independent partner clinicians — never with Livozo.

Clinical context

How to read this page.

These pages describe possible pathways, not a promise that any medication will be prescribed, shipped this week, or available in any state today. Livozo does not employ the prescriber.

Compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents of branded GLP-1 medicines. Livozo does not prescribe. A partner clinician must review history and clinical need. This page is a care-path listing, not a promise that medication will be prescribed or shipped.
  • Weight-optimization goals a clinician may review
  • Metabolic context discussed with a partner clinician
  • Interest in semaglutide or tirzepatide under medical review

Partner model

What the partner path can include.

When Launchpad is wired

  • Livozo marketing CTA, then OpenLoop white-label intake
  • Review by OpenLoop-affiliated licensed clinicians
  • Patient-specific 503A compounding through their pharmacy network when appropriate
  • Partner-hosted portal, shipping, and support — not a Livozo clinic

Potential options

  • Compounded semaglutide when a clinician documents need
  • Compounded tirzepatide when a clinician documents need
  • Not interchangeable with FDA-approved branded GLP-1s

Exact medication, formulation, quantity, refill timing, and pharmacy routing depend on the clinical partner, applicable law, and clinical appropriateness. OpenLoop's licensed 503A network — not an exclusive Red Rock claim — fulfills partner prescriptions if written.

Next step

See if you qualify — partner intake, not a live clinic.

This is a Launchpad care path, not live clinician care. A “see if I qualify” step is meant to hand off to OpenLoop white-label intake when that contract is wired. Until then, eligibility is informational. No prescription, charge, or shipment happens from this site.

See if I qualify